To gain further insights, we generated cancer cell lines with inducible expression of V1A-23 aa (a peptide that inhibits ATP6V1A ubiquitination) by disrupting the interaction between FBXO9 and ATP6V1A (Supplementary Fig. S6A-D). The gene discussed is FBXO9; the disease is cancer.